Woodstock Corp Bluebird Bio, Inc. Transaction History

Woodstock Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$8.96 - $16.31 $92,368 - $168,139	-10,309 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$11.24 - $21.0 $134 - $252	-12 Reduced 0.12%	10,309 $197,000
Q1 2021 Apr 05, 2021	BUY	$16.59 - $33.89 $64,916 - $132,611	3,913 Added 61.06%	10,321 $311,000
Q1 2019 Apr 05, 2019	BUY	$64.44 - $104.11 $8,828 - $14,263	137 Added 2.18%	6,408 $1.01 Million
Q4 2017 Jan 24, 2018	SELL	$81.25 - $130.7 $89,131 - $143,377	-1,097 Reduced 14.89%	6,271 $1.12 Million
Q3 2017 Oct 06, 2017	BUY	$57.74 - $91.42 $425,428 - $673,582	7,368	7,368 $1.01 Million

134

63.1M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $582M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

Stay updated on Woodstock Corp with notifications on news.